RS52777B - Terapijski sistem sa trenutnim otpuštanjem za poboljšanu oralnu apsorpciju 7-[(e)-tert-butiloksiiminometil] kamptotecina - Google Patents
Terapijski sistem sa trenutnim otpuštanjem za poboljšanu oralnu apsorpciju 7-[(e)-tert-butiloksiiminometil] kamptotecinaInfo
- Publication number
- RS52777B RS52777B RS20130196A RSP20130196A RS52777B RS 52777 B RS52777 B RS 52777B RS 20130196 A RS20130196 A RS 20130196A RS P20130196 A RSP20130196 A RS P20130196A RS 52777 B RS52777 B RS 52777B
- Authority
- RS
- Serbia
- Prior art keywords
- pharmaceutical formulation
- formulation according
- active principle
- capsule
- amphiphilic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000418A ITRM20050418A1 (it) | 2005-08-04 | 2005-08-04 | Sistemi terapeutici a rilascio immediato per il migliorato assorbimento orale di 7-[(e)-t-butilossimminometil] camptotecina. |
| PCT/EP2006/064111 WO2007017331A2 (en) | 2005-08-04 | 2006-07-11 | Immediate release therapeutic systems for improved oral absorption of 7- [ (e) -tert-butyloxyiminomethyl] camptothecin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS52777B true RS52777B (sr) | 2013-10-31 |
Family
ID=37727667
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RS20130196A RS52777B (sr) | 2005-08-04 | 2006-07-11 | Terapijski sistem sa trenutnim otpuštanjem za poboljšanu oralnu apsorpciju 7-[(e)-tert-butiloksiiminometil] kamptotecina |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20090053307A1 (enExample) |
| EP (1) | EP1915153B1 (enExample) |
| JP (1) | JP5225084B2 (enExample) |
| KR (1) | KR101301548B1 (enExample) |
| CN (1) | CN101287466B (enExample) |
| AU (1) | AU2006278114B2 (enExample) |
| BR (1) | BRPI0614471A2 (enExample) |
| CA (1) | CA2612080C (enExample) |
| CY (1) | CY1114311T1 (enExample) |
| DK (1) | DK1915153T3 (enExample) |
| ES (1) | ES2407408T3 (enExample) |
| HR (1) | HRP20130364T1 (enExample) |
| IT (1) | ITRM20050418A1 (enExample) |
| MX (1) | MX2008001029A (enExample) |
| PL (1) | PL1915153T3 (enExample) |
| PT (1) | PT1915153E (enExample) |
| RS (1) | RS52777B (enExample) |
| SI (1) | SI1915153T1 (enExample) |
| WO (1) | WO2007017331A2 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2519193C2 (ru) | 2008-09-12 | 2014-06-10 | Критикал Фармасьютикалс Лимитед | Усовершенствование всасывания терапевтических средств через слизистые оболочки или кожу |
| USD618617S1 (en) | 2008-12-30 | 2010-06-29 | Multiway Industries (Hk) Ltd. | Three way electrical plug |
| US7892036B2 (en) * | 2008-12-30 | 2011-02-22 | Multiway Industries (Hk) Ltd. | Electrical wall tap assembly |
| USD618175S1 (en) | 2009-10-15 | 2010-06-22 | Multiway Industries (Hk) Ltd. | Three-outlet surge-protected adaptor |
| USD616823S1 (en) | 2009-10-15 | 2010-06-01 | Multiway Industries (Hk) Ltd. | Single-outlet surge-protected adaptor |
| EP2510924B1 (en) * | 2009-12-08 | 2014-10-08 | IL Hwa Co., Ltd | SOLID DISPERSIONS CONTAINING 20-O-ß-D-GLUCOPYRANOSYL-20(S)-PROTOPANAXADIOL |
| USD651977S1 (en) | 2011-01-10 | 2012-01-10 | Multiway Industries (Hk) Ltd. | Multiple outlet electrical connector |
| CN108066311B (zh) * | 2017-12-26 | 2020-09-08 | 兆科（广州）肿瘤药物有限公司 | 一种吉马替康胶囊及其制备方法 |
| USD958079S1 (en) | 2019-08-30 | 2022-07-19 | Multiway Industries (Hk) Ltd. | 3-way electrical tap |
| USD955993S1 (en) | 2019-08-30 | 2022-06-28 | Multiway Industries (Hk) Ltd. | 3-way electrical tap |
| CN111529497A (zh) * | 2020-02-11 | 2020-08-14 | 兆科（广州）肿瘤药物有限公司 | 一种吉马替康药物固体分散组合物及其制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5726181A (en) * | 1995-06-05 | 1998-03-10 | Bionumerik Pharmaceuticals, Inc. | Formulations and compositions of poorly water soluble camptothecin derivatives |
| NZ502569A (en) * | 1997-07-29 | 2002-05-31 | Upjohn Co | Self-emulsifying formulation for lipophilic compounds comprising a mixture of diglyceride and monoglyceride in a ratio of 9:1 to 6:4 |
| AR013261A1 (es) * | 1997-08-01 | 2000-12-13 | Smithkline Beecham Corp | Formulaciones farmaceuticas para analogos de camptotecina en capsula de gelatina |
| US7030155B2 (en) * | 1998-06-05 | 2006-04-18 | Sonus Pharmaceuticals, Inc. | Emulsion vehicle for poorly soluble drugs |
| PT1044977E (pt) * | 1999-03-09 | 2002-09-30 | Sigma Tau Ind Farmaceuti | Derivados de camptotecina com actividade antitumoral |
| AU5273200A (en) * | 1999-05-24 | 2000-12-12 | Sonus Pharmaceuticals, Inc. | Emulsion vehicle for poorly soluble drugs |
| CN101480395A (zh) * | 2004-03-26 | 2009-07-15 | 诺瓦提斯公司 | 喜树碱衍生物以固定给药方案治疗增生性疾病的用途 |
| GT200500310A (es) * | 2004-11-19 | 2006-06-19 | Compuestos organicos | |
| PL1828196T3 (pl) * | 2004-12-21 | 2013-02-28 | Sigma Tau Ind Farmaceuti | Stereoselektywny sposób wytwarzania i krystaliczne formy kamptotecyny |
-
2005
- 2005-08-04 IT IT000418A patent/ITRM20050418A1/it unknown
-
2006
- 2006-07-11 JP JP2008524462A patent/JP5225084B2/ja not_active Expired - Fee Related
- 2006-07-11 SI SI200631573T patent/SI1915153T1/sl unknown
- 2006-07-11 RS RS20130196A patent/RS52777B/sr unknown
- 2006-07-11 PT PT67777102T patent/PT1915153E/pt unknown
- 2006-07-11 BR BRPI0614471-3A patent/BRPI0614471A2/pt not_active Application Discontinuation
- 2006-07-11 CN CN200680027844.9A patent/CN101287466B/zh active Active
- 2006-07-11 WO PCT/EP2006/064111 patent/WO2007017331A2/en not_active Ceased
- 2006-07-11 MX MX2008001029A patent/MX2008001029A/es active IP Right Grant
- 2006-07-11 DK DK06777710.2T patent/DK1915153T3/da active
- 2006-07-11 CA CA2612080A patent/CA2612080C/en not_active Expired - Fee Related
- 2006-07-11 US US11/993,328 patent/US20090053307A1/en not_active Abandoned
- 2006-07-11 EP EP06777710.2A patent/EP1915153B1/en active Active
- 2006-07-11 AU AU2006278114A patent/AU2006278114B2/en not_active Ceased
- 2006-07-11 HR HRP20130364TT patent/HRP20130364T1/hr unknown
- 2006-07-11 PL PL06777710T patent/PL1915153T3/pl unknown
- 2006-07-11 ES ES06777710T patent/ES2407408T3/es active Active
- 2006-07-11 KR KR1020087003092A patent/KR101301548B1/ko not_active Expired - Fee Related
-
2013
- 2013-04-25 CY CY20131100341T patent/CY1114311T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007017331A3 (en) | 2007-09-27 |
| BRPI0614471A2 (pt) | 2011-03-29 |
| MX2008001029A (es) | 2008-03-14 |
| ES2407408T3 (es) | 2013-06-12 |
| HRP20130364T1 (hr) | 2013-05-31 |
| CA2612080A1 (en) | 2007-02-15 |
| AU2006278114B2 (en) | 2011-06-23 |
| US20090053307A1 (en) | 2009-02-26 |
| PL1915153T3 (pl) | 2013-09-30 |
| CN101287466A (zh) | 2008-10-15 |
| EP1915153A2 (en) | 2008-04-30 |
| KR20080031945A (ko) | 2008-04-11 |
| PT1915153E (pt) | 2013-06-05 |
| ITRM20050418A1 (it) | 2007-02-05 |
| JP5225084B2 (ja) | 2013-07-03 |
| WO2007017331A2 (en) | 2007-02-15 |
| KR101301548B1 (ko) | 2013-09-06 |
| CA2612080C (en) | 2013-09-03 |
| HK1125293A1 (en) | 2009-08-07 |
| CN101287466B (zh) | 2014-11-05 |
| DK1915153T3 (da) | 2013-06-24 |
| JP2009503013A (ja) | 2009-01-29 |
| AU2006278114A1 (en) | 2007-02-15 |
| CY1114311T1 (el) | 2016-08-31 |
| EP1915153B1 (en) | 2013-04-10 |
| SI1915153T1 (sl) | 2013-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chaudhari et al. | Application of surfactants in solid dispersion technology for improving solubility of poorly water soluble drugs | |
| RS53209B (sr) | Farmaceutska kompozicija za inhibitor proteaze virusnog hepatitis c | |
| JP2010510980A (ja) | 腸送達系のためのナフトキノンベース化合物を含有する医薬組成物 | |
| BRPI0414000B1 (pt) | composição farmacêutica sólida oral de liberação prolongada contendo tacrolimus na forma de uma dispersão sólida, forma de dosagem, e, uso da composição farmacêutica | |
| US20090181094A1 (en) | Molecular Cage for Sustained Release Control of Pharmaceutical and Cosmetic Agents | |
| RS52777B (sr) | Terapijski sistem sa trenutnim otpuštanjem za poboljšanu oralnu apsorpciju 7-[(e)-tert-butiloksiiminometil] kamptotecina | |
| KR100669497B1 (ko) | 안정성과 용출률이 뛰어난 약리학적 조성물 및 그 제조방법 | |
| CN119421703A (zh) | 无定形固体分散体和包含所述无定形固体分散体的药物组合物 | |
| WO2016126058A2 (ko) | 두타스테라이드 함유 고체 분산체 및 이를 포함하는 조성물 | |
| JPH0112729B2 (enExample) | ||
| EP2654723A1 (en) | Solid pharmaceutical dosage forms comprising tadalafil and methods of preparation thereof | |
| TW202345842A (zh) | Ｐｒｏｔａｃ化合物之醫藥組合物及其用途 | |
| CN101106995B (zh) | 在非水极性溶剂中增加溶解度的10-羟基喜树碱类化合物的药物制剂 | |
| WO2012095151A1 (en) | Solid pharmaceutical dosage forms comprising tadalafil and methods of preparation thereof | |
| TWI597063B (zh) | 藥物組成物及其製備方法 | |
| RS52697B (sr) | Stabilna čvrsta disperzija derivata vinka alkaloida i postupak za njenu proizvodnju | |
| HK1125293B (en) | Immediate release therapeutic systems for improved oral absorption of 7-[(e)-tertbutyloxyiminoxmethyl] camptothecin | |
| DK2654723T3 (en) | Solid pharmaceutical dosage forms comprising tadalafil and processes for their preparation | |
| KR100535228B1 (ko) | 란소프라졸함유 경질캅셀제의 제조방법 | |
| KR101012903B1 (ko) | 나노입자 형성을 이용하는 리세드로네이트 경질캡슐 | |
| WO2017045603A1 (zh) | 一种含喜树碱衍生物的注射制剂、其注射液、制备和应用 | |
| JP5321454B2 (ja) | 医薬錠剤の製造法 | |
| JP2019085411A (ja) | 固形医薬組成物 | |
| HK1120437A (en) | Pharmaceutical formulation with high stability and dissolution and manufacturing process | |
| KR20040097900A (ko) | 슈도에페드린 또는 그의 염의 방출제어형 약제학적 조성물 |